Stock UniverseDerived research view · source repositories remain read-only

Gilead Sciences, Inc. (GILD)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - General
Score Band
Qualified
Selection Score
36.09
Global Rank
1074
Market Cap
184.91B
Latest Close
129.16
RS Composite
-9.21% · G#2032

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-5.24%
3M
-9.75%
6M
4.60%
1Y
21.62%
3Y
85.84%
5Y
135.39%
10Y
111.20%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 13.41M · 30-day average: 7.10M · Max drawdown over stored range: -30.47%

Research Snapshot

Relative Strength vs SPX

RS Composite-9.21%
20D RS-4.29%
60D RS-20.00%
120D RS-0.87%
Global RS Rank2032 · 39.43% percentile
Qualified+ RS Rank761 · 39.51% percentile
Group ScopeQualified+
Primary RS Rank197 · 56.99% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank182 / 701
Primary Percentile74.18
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-0729.74Bn/a10.37B9.22B7.3515.15B891.00M14.26B1,254Mn/a34.88%30.99%50.94%47.94%7.64B20.86B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$7.3517.6x$23.725.4x$11.3711.4x$12.0810.7x

Shares Diluted: 1,254M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue2730527281271162875429443
Revenue Growth (YoY)10.596%-0.088%-0.605%6.041%2.396%
Gross Profit2177921624210972250323213
Operating Income119321097492771068711817
Free Cash Flow1080583447421103059456
Free Cash Flow Per Share8.5626.6125.8998.2117.535
EPS (Diluted) GAAP4.933.644.50.386.78
EPS Growth4938.221%-26.166%23.626%-91.556%1684.211%
EPS Non-GAAP
Gross Margin79.762%79.264%77.803%78.26%78.84%
Operating Margin43.699%40.226%34.212%37.167%40.135%
Profit Margin22.798%16.832%20.892%1.669%28.903%
Free Cash Flow Margin39.572%30.585%27.368%35.838%32.116%
Shares Outstanding (Diluted)12621262125812551255
Shares Change (YoY)-0.079%3900%-0.317%-0.238%3900%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-076.96Bn/a2.59B37.16%2.02B29.04%1.611.25B7.64B20.86Bprocessed
2025 Q42026-02-247.92Bn/a1.98B25.03%2.18B27.55%1.741.25B7.63B22.13Bprocessed
2025 Q32025-11-077.77Bn/a3.33B42.82%3.05B39.28%2.431.25B7.35B22.14Bprocessed
2025 Q22025-08-077.08Bn/a2.47B34.93%1.96B27.68%1.561.25B5.21B22.14Bprocessed
2025 Q12025-05-076.67Bn/a2.24B33.55%1.31B19.72%1.041.26B7.93B22.15Bprocessed
2024 Q42025-02-287.57Bn/a2.45B32.40%1.78B23.56%1.391.28B11.17B24.90Bprocessed
2024 Q32024-11-127.54Bn/a888.00M11.77%1.25B16.61%1.001.25B6.22B21.44Bprocessed
2024 Q22024-08-086.95Bn/a2.64B38.02%1.61B23.21%1.291.25B3.95B21.54Bprocessed
2024 Q12024-05-086.69Bn/a-4.32B-64.64%-4.17B-62.37%-3.341.25B5.90B21.53Bprocessed
2023 Q42024-02-237.11Bn/a1.61B22.66%1.43B20.09%1.141.25B7.26B23.19Bprocessed
2023 Q32023-11-077.05Bn/a2.62B37.20%2.18B30.92%1.731.26B6.86B23.19Bprocessed
2023 Q22023-08-046.60Bn/a1.67B25.23%1.04B15.84%0.831.26B6.67B21.21Bprocessed
2023 Q12023-05-036.35Bn/a1.71B26.84%1.01B15.90%0.801.26B5.87B22.96Bprocessed
2022 Q42023-02-227.39Bn/a2.27B30.68%1.64B22.20%1.301.26B6.38B22.96Bprocessed
2022 Q32022-11-027.04Bn/a2.84B40.29%1.79B25.40%1.421.26B5.66B22.95Bprocessed
2022 Q22022-08-086.26Bn/a2.03B32.41%1.14B18.27%0.911.26B5.66B25.20Bprocessed
2022 Q12022-05-046.59Bn/a197.00M2.99%19.00M0.29%0.021.26B5.33B25.18Bprocessed
2021 Q42022-02-237.24Bn/a940.00M12.98%382.00M5.27%0.301.26B6.52B25.18Bprocessed
2021 Q32021-11-037.42Bn/a3.84B51.77%2.59B34.93%2.051.26B5.74B25.18Bprocessed
2021 Q22021-08-056.22Bn/a2.25B36.13%1.52B24.48%1.211.26B6.53B27.91Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.